DOI: 10.2337/diacare.29.01.06.dc05-1670 © 2006 by the American Diabetes Association
Urinary Connective Tissue Growth Factor Excretion Correlates With Clinical Markers of Renal Disease in a Large Population of Type 1 Diabetic Patients With Diabetic Nephropathy
1 Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands Address correspondence and reprint requests to Tri Q. Nguyen, University Medical Center Utrecht, Department of Pathology, H04.312, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands. E-mail: t.q.nguyen{at}lab.azu.nl OBJECTIVELevels of connective tissue growth factor (CTGF; CCN-2) in plasma are increased in various fibrotic disorders, including diabetic nephropathy. Recently, several articles have reported a strong increase of urinary CTGF excretion (U-CTGF) in patients with diabetic nephropathy. However, these studies addressed too small a number of patients to allow general conclusions to be drawn. Therefore, we evaluated U-CTGF in a large cross-sectional study of patients with type 1 diabetes. RESEARCH DESIGN AND METHODSSubjects were 318 type 1 diabetic patients and 29 normoglycemic control subjects. U-CTGF was measured by sandwich enzyme-linked immunosorbent assay. Groups were compared by Kruskal-Wallis and Mann-Whitney analysis. The relation between U-CTGF and markers of diabetic nephropathy was determined by regression analysis. RESULTSU-CTGF in patients with diabetic nephropathy (n = 89, median 155 pmol/24 h [interquartile range 96258]) was significantly higher than in microalbuminuric (n = 79, 100 [6578]) and normoalbuminuric (n = 150, 85 [48127]) patients and control subjects (n = 29, 100 [78114]). U-CTGF correlated with urinary albumin excretion (UAE) (R = 0.31) and glomerular filtration rate (R = 0.38) in patients with diabetic nephropathy. A standardized increase in U-CTGF was associated with diabetic nephropathy (odds ratio 2.3 [95% CI 1.73.1]), which was comparable with the odds ratios for diabetic nephropathy of increased HbA1c (2.0 [1.52.7]), and blood pressure (2.0 [1.52.6]). CONCLUSIONSThis is the first large cross-sectional study addressing U-CTGF in human type 1 diabetes. The observed association of U-CTGF with UAE and glomerular filtration rate might reflect a role of CTGF as progression promoter in diabetic nephropathy.
Abbreviations: ARB, angiotensin II receptor blocker CTGF, connective tissue growth factor GFR, glomerular filtration rate UAE, urinary albumin excretion U-CTGF, urinary CTGF excretion
|
|
|
|||||||||||||||||||||||||||